Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

NCT05867212 is registered in ClinicalTrials.gov with Kelley-Ross & Associates, Inc. as lead sponsor.

NCT NCT05867212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05867212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.
Lead sponsor
Kelley-Ross & Associates, Inc.
Phase
Observational
Overall status
Completed
Start date
May 13, 2023
Completion date
April 30, 2025
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections